Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Usana Health Sciences (USNA) Income from Continuing Operations (2016 - 2025)

Historic Income from Continuing Operations for Usana Health Sciences (USNA) over the last 16 years, with Q3 2025 value amounting to -$6.7 million.

  • Usana Health Sciences' Income from Continuing Operations fell 16280.76% to -$6.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.6 million, marking a year-over-year decrease of 6769.35%. This contributed to the annual value of $42.1 million for FY2024, which is 3406.28% down from last year.
  • Usana Health Sciences' Income from Continuing Operations amounted to -$6.7 million in Q3 2025, which was down 16280.76% from $10.4 million recorded in Q2 2025.
  • Usana Health Sciences' Income from Continuing Operations' 5-year high stood at $38.2 million during Q3 2021, with a 5-year trough of -$9.7 million in Q1 2022.
  • Over the past 5 years, Usana Health Sciences' median Income from Continuing Operations value was $16.5 million (recorded in 2024), while the average stood at $15.0 million.
  • In the last 5 years, Usana Health Sciences' Income from Continuing Operations surged by 33396.27% in 2022 and then plummeted by 16280.76% in 2025.
  • Quarter analysis of 5 years shows Usana Health Sciences' Income from Continuing Operations stood at $27.3 million in 2021, then fell by 16.57% to $22.8 million in 2022, then dropped by 26.47% to $16.8 million in 2023, then tumbled by 73.26% to $4.5 million in 2024, then tumbled by 248.57% to -$6.7 million in 2025.
  • Its Income from Continuing Operations stands at -$6.7 million for Q3 2025, versus $10.4 million for Q2 2025 and $9.3 million for Q1 2025.